SF 953
Latest Information Update: 13 Jun 2001
At a glance
- Originator Unknown
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 13 Jun 2001 No-Development-Reported for HIV-1 infections (Unknown route)
- 27 May 1998 New profile
- 27 May 1998 Preclinical development for HIV-1 infections (Unknown route)